Document Detail

Clinical significance of anticardiolipin and anti-beta2-glycoprotein I antibodies.
MedLine Citation:
PMID:  15345914     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Anticardiolipin (aCl) and anti-beta2-glycoprotein I (anti-beta2-gpI) antibodies are autoantibodies associated with the antiphospholipid syndrome (APS), which is characterized by both arterial and venous thrombosis and miscarriages. The scope of this study was to explore the clinical characteristics of patients with aCl and anti-beta2-gpI antibodies. METHODS: ACl were tested in 3,600 consecutive sera in our laboratory between January 1999 and June 2001. The clinical diagnosis and prevalence of thrombosis and pregnancy morbidity were retrospectively reviewed in aCl-positive patients. Furthermore, the frequency of anti-beta2-gpI antibodies, lupus anticoagulant (LA), prolonged activated partial thromboplastin time (aPTT), and thrombocytopenia were investigated in aCl-positive patients. RESULTS: 147 aCl-positive patients, 110 women and 37 men with a mean age of 41 years (range 7.8-82.5), were identified. 42 (28.6%) aCl-positive patients fulfilled the criteria for APS which was secondary to a connective tissue disorder in 8 patients. The frequency of anti-beta2-gpI antibodies and LA, prolonged aPTT, and thrombocytopenia in aCl-positive patients was 23.8, 27.2, 25.7 and 9.2%, respectively. The presence of both aCl and anti-beta2-gpI antibodies was strongly associated with clinical symptoms of APS (p = 0.007) compared to p = 0.008 for LA. CONCLUSION: Our data suggest that assessment of anti-beta2-gpI antibodies in addition to aCl is a valuable diagnostic tool in the workup of patients with APS.
Gerlinde Obermoser; Waltraud Bitterlich; Friedebert Kunz; Norbert T Sepp
Related Documents :
11315344 - Azathioprine therapy for patients with systemic lupus erythematosus.
19839494 - Urticarial vasculitis: etiologies and clinical course.
1681024 - Systemic lupus erythematosus complicated with cystitis, obstructive uropathy and intrac...
7763104 - Loss of bone mineral density in premenopausal women with systemic lupus erythematosus.
16718444 - Tracheobronchial aspiration of foreign bodies: current indications for emergency plain ...
25020874 - P492association of oxidative stress and cardiovascular risk in hemodialysis patients: r...
Publication Detail:
Type:  Journal Article     Date:  2004-09-02
Journal Detail:
Title:  International archives of allergy and immunology     Volume:  135     ISSN:  1018-2438     ISO Abbreviation:  Int. Arch. Allergy Immunol.     Publication Date:  2004 Oct 
Date Detail:
Created Date:  2004-10-06     Completed Date:  2004-11-19     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9211652     Medline TA:  Int Arch Allergy Immunol     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  148-53     Citation Subset:  IM    
Department of Dermatology, University Hospital of Innsbruck, Innsbruck, Austria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Antibodies / blood
Antibodies, Anticardiolipin / blood*
Antiphospholipid Syndrome / blood,  complications,  diagnosis*
Connective Tissue Diseases / complications,  epidemiology
Fetal Death
Glycoproteins / immunology*
Lupus Coagulation Inhibitor / blood
Middle Aged
Partial Thromboplastin Time
Sensitivity and Specificity
Thrombocytopenia / epidemiology
Thrombosis / epidemiology
beta 2-Glycoprotein I
Reg. No./Substance:
0/Antibodies; 0/Antibodies, Anticardiolipin; 0/Glycoproteins; 0/Lupus Coagulation Inhibitor; 0/beta 2-Glycoprotein I

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Comparison of the effects in the nose and skin of a single dose of desloratadine and levocetirizine ...
Next Document:  Canine mast cell activation via human IgG1 and IgG4.